Amitell Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Amitell Capital’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$611K	Hold	178,769	–	–	0.56%	23
2026 Q1	$640K	Hold	178,769	–	–	1.03%	13
2025 Q4	$627K	Hold	178,769	–	–	0.7%	20
2025 Q3	$583K	Sell	178,769 -48,231	-21%	-$152K	0.36%	41
2025 Q2	$556K	Buy	+227,000	New	+$1.15M	0.29%	40
2022 Q3	–	Sell	-97,331	Closed	-$1.34M	–	28
2022 Q2	$1.34M	Hold	97,331	–	–	3.05%	11
2022 Q1	$1.54M	Buy	+97,331	New	+$1.68M	0.9%	43

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Amitell Capital's RCKT Position: Q2 2026 in Review

Amitell Capital held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 178,769 shares worth $611K. The position accounts for 0.56% of the portfolio, ranked #23.

Amitell Capital first reported a position in RCKT in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.54M in Q1 2022. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Amitell Capital held 178,769 shares of Rocket Pharmaceuticals worth $611K as of Q2 2026.
Amitell Capital left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
Rocket Pharmaceuticals made up 0.56% of Amitell Capital's portfolio in Q2 2026, its #23 holding.
Amitell Capital first reported a position in Rocket Pharmaceuticals in Q1 2022 and has held it in 7 quarters since.
Amitell Capital's Rocket Pharmaceuticals position peaked at $1.54M in Q1 2022.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Amitell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.